Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
about
Development of next generation cardiovascular therapeutics through bio-assisted nanotechnology.Aggf1 attenuates neuroinflammation and BBB disruption via PI3K/Akt/NF-κB pathway after subarachnoid hemorrhage in rats.Losartan Alleviates Renal Fibrosis and Inhibits Endothelial-to-Mesenchymal Transition (EMT) Under High-Fat Diet-Induced Hyperglycemia
P2860
Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Targeting AGGF1 (angiogenic fa ...... rmation After Vascular Injury.
@en
Targeting AGGF1
@nl
type
label
Targeting AGGF1 (angiogenic fa ...... rmation After Vascular Injury.
@en
Targeting AGGF1
@nl
prefLabel
Targeting AGGF1 (angiogenic fa ...... rmation After Vascular Injury.
@en
Targeting AGGF1
@nl
P2093
P2860
P356
P1476
Targeting AGGF1 (angiogenic fa ...... ormation After Vascular Injury
@en
P2093
Changqing Hu
Chengqi Xu
Qiuyun Chen
Qixue Song
Xingwen Da
Yufeng Yao
Zhenkun Hu
P2860
P356
10.1161/JAHA.117.005889
P50
P577
2017-06-25T00:00:00Z